Latest close
$250.83
As of Oct 2, 2026
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| AltaRock Partners | 32.21% | 5,729,972 | TRIMMED (-24.3%) |
| Greenlea Lane Capital | 18.35% | 280,350 | TRIMMED (-10.3%) |
| Baupost Group | 16.48% | 3,743,854 | ADDED (+20.0%) |
| ShawSpring Partners | 16.13% | 157,020 | TRIMMED (-15.8%) |
| Appaloosa Management | 15.43% | 5,000,000 | ADDED (+15.7%) |
| ValueAct Capital | 12.44% | 2,941,700 | ADDED (+2.0%) |
| Pershing Square Capital Management | 10.49% | 8,563,857 | NEW |
| Tiger Global Management | 9.62% | 9,683,558 | TRIMMED (-3.2%) |
| Triple Frond Partners | 9.20% | 432,420 | TRIMMED (-9.6%) |
| Third Point | 8.91% | 1,750,000 | TRIMMED (-9.8%) |
| Egerton Capital | 8.23% | 3,573,408 | ADDED (+51.2%) |
| Vulcan Value Partners | 7.20% | 992,758 | TRIMMED (-37.8%) |
| Wedgewood Partners | 6.66% | 135,440 | ADDED (+35.6%) |
| AKO Capital | 6.34% | 1,141,835 | TRIMMED (-34.0%) |
| Jensen Investment Management | 6.09% | 1,054,136 | TRIMMED (-13.6%) |
| Polen Capital Management | 5.77% | 2,809,953 | TRIMMED (-27.9%) |
| Mairs & Power Funds | 5.68% | 2,599,441 | TRIMMED (-0.1%) |
| Patient Capital Management | 5.32% | 681,047 | ADDED (+4.1%) |
| Davis Advisors | 4.38% | 4,276,176 | ADDED (+24.8%) |
| Maverick Capital | 4.25% | 2,020,894 | TRIMMED (-12.8%) |
| First Pacific Advisors | 4.01% | 1,360,585 | TRIMMED (-3.9%) |
| Markel Group | 3.69% | 2,030,760 | HELD |
| Weitz Investment Management | 3.59% | 217,500 | TRIMMED (-2.2%) |
| Matrix Asset Advisors | 2.59% | 133,816 | TRIMMED (-1.2%) |
| Sound Shore | 2.57% | 350,136 | TRIMMED (-7.6%) |
| Viking Global Investors | 2.51% | 3,700,862 | ADDED (+209.6%) |
| Torray Funds | 2.19% | 68,062 | TRIMMED (-5.2%) |
| Dodge & Cox Funds | 2.08% | 16,708,513 | ADDED (+10.6%) |
| Oakmark Funds | 1.47% | 4,653,406 | TRIMMED (-2.3%) |
| Check Capital Management | 1.31% | 206,057 | ADDED (+1.0%) |
| Leon Cooperman | 1.14% | 169,500 | HELD |
| Century Management | 0.09% | 1,807 | HELD |
| Brave Warrior Advisors | 0.01% | 2,650 | ADDED (+89.3%) |
| Gardner Russo & Quinn | 0.00% | 936 | TRIMMED (-10.0%) |
Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.
| Institutions holding | 6,145 of 8,857 filers |
| Long-only filers among them | 6,126 |
| Change vs 2026 Q1 | +209 net · 1,843 entered · 1,634 exited |
| Shares reported, all filers | 7,151,104,181 |
| Reported value, all filers | $1,728.4B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 26 sales by 7 insiders ($364.8M).
Source: SEC Form 4 filings, as of Oct 3, 2026. Open-market transactions only.
2 House members reported buying (3 purchases vs 4 sales). Bought by Democrats and Republicans. Latest buy: Jul 8, 2026.
Source: U.S. House Clerk STOCK Act periodic transaction reports, as of Oct 3, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade. Senate reports are not included yet.
Politicians
· Bought by Members — Last 6 months: bought by a U.S. House member
· Bought by Both Parties — Last 6 months: bought by both Democratic and Republican members
Financial Screens
· Growth — Revenue up every year for 5 straight years
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
Key figures
· Growth — Latest revenue: $177.9B · 5-yr revenue CAGR: 23.8% · Straight growth years: 10
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 2.18 · Operating cash flow: $139.5B · Net income: $77.7B
· Bought by Members — Members buying: 2 · Buy txns: 3 · Sell txns: 4 · Latest buy: Jul 8, 2026
· Bought by Both Parties — Members buying: 2 · Buy txns: 3 · Sell txns: 4 · Latest buy: Jul 8, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Super-investor 13F BEST — appeared in 20 of the last 20 quarterly lists; latest 2026 Q2, ranked #3 of 50.
· Politician BEST — appeared in 16 of the last 20 quarterly lists; latest 2026 Q2, ranked #41 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 18 | 61.1% | +3.0% | +2.8% | +0.1% |
| Share count tripled (3x) | 7 | 85.7% | +7.4% | +3.7% | +3.7% |
| Heavy exit — 3+ tracked funds sold out together | 4 | 75.0% | +5.2% | +5.5% | -0.4% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.